LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 51

Search options

  1. Book: Photopheresis in the treatment of cutaneous T-cell lymphoma

    Zic, John A.

    current status

    (Current opinion in oncology ; 24, Suppl. 1)

    2012  

    Author's details [John A. Zic]
    Series title Current opinion in oncology ; 24, Suppl. 1
    Collection
    Language English
    Size S10 S. : Ill.
    Publisher Wolters Kluwer Health/Lippincott Williams & Wilkins
    Publishing place London
    Publishing country Great Britain
    Document type Book
    HBZ-ID HT017124314
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  2. Article ; Online: Diagnosis and Management of Cutaneous Lymphomas Including Cutaneous T-cell Lymphoma.

    Zic, John A

    The Medical clinics of North America

    2021  Volume 105, Issue 4, Page(s) 737–755

    Abstract: The cutaneous lymphomas are malignancies of T-cell and B-cell lymphocytes in which the skin is the primary organ of involvement. The cutaneous T-cell lymphomas include variants that can mimic the presentation of common skin diseases or arthropod bites. ... ...

    Abstract The cutaneous lymphomas are malignancies of T-cell and B-cell lymphocytes in which the skin is the primary organ of involvement. The cutaneous T-cell lymphomas include variants that can mimic the presentation of common skin diseases or arthropod bites. Mycosis fungoides, the most common cutaneous T-cell lymphoma, usually presents as fixed asymptomatic patches or plaques in sun-protected areas. The cutaneous B-cell lymphomas have fewer variants that often present as papules or nodules that can mimic nonmelanoma skin cancers. Some therapies for cutaneous lymphoma have unique side effects such as central hypothyroidism, hyperlipidemia, and peripheral neuropathy.
    MeSH term(s) Aged ; Aged, 80 and over ; Animals ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents, Immunological/adverse effects ; Arthropods ; Bexarotene/adverse effects ; Bites and Stings/diagnosis ; Brentuximab Vedotin/adverse effects ; Diagnosis, Differential ; Humans ; Hyperlipidemias/chemically induced ; Hypothyroidism/chemically induced ; Lymphoma, Primary Cutaneous Anaplastic Large Cell/diagnosis ; Lymphoma, T-Cell, Cutaneous/classification ; Lymphoma, T-Cell, Cutaneous/diagnosis ; Lymphoma, T-Cell, Cutaneous/therapy ; Lymphomatoid Papulosis/diagnosis ; Mycosis Fungoides/diagnosis ; Peripheral Nervous System Diseases/chemically induced ; Prognosis ; Sezary Syndrome/diagnosis ; Skin Diseases/diagnosis ; Skin Diseases/pathology ; Skin Neoplasms/pathology
    Chemical Substances Antineoplastic Agents ; Antineoplastic Agents, Immunological ; Brentuximab Vedotin (7XL5ISS668) ; Bexarotene (A61RXM4375)
    Language English
    Publishing date 2021-05-31
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 215710-x
    ISSN 1557-9859 ; 0025-7125
    ISSN (online) 1557-9859
    ISSN 0025-7125
    DOI 10.1016/j.mcna.2021.04.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Evaluating the Role of Competency-Based Behavioral Interviewing in Holistic Medical School Admissions.

    Davidson, Mario A / Russell, Regina G / Walker, Philip D / Zic, John A / Churchill, Larry R / Fuchs, D Catherine / Miller, Bonnie M

    Academic medicine : journal of the Association of American Medical Colleges

    2024  

    Abstract: Problem: Holistic review is a multifaceted concept that aims to increase diversity and applicant fit with program needs by complementing traditional academic requirements with appraisal of a wider range of personal characteristics and experiences. ... ...

    Abstract Problem: Holistic review is a multifaceted concept that aims to increase diversity and applicant fit with program needs by complementing traditional academic requirements with appraisal of a wider range of personal characteristics and experiences. Behavioral interviewing has been practiced and studied in human resources, business, and organizational psychology for over 50 years. Its premise is that future performance can be anticipated from past actions. However, many of the interview approaches within the holistic framework are resource intensive and logistically challenging.
    Approach: The Vanderbilt University School of Medicine instituted a competency-based behavioral interview (CBBI) to augment the selection process in 2012. Behavioral interviews are based on key competencies needed for entering students and require applicants to reflect on their actual experiences and what they learned from them. The authors reviewed 5 years of experience (2015-2019) to evaluate how CBBI scores contributed to the overall assessment of applicants for admission.
    Outcomes: The final admission committee decision for each applicant was determined by reviewing multiple factors, with no single assessment determining the final score. The CBBI and summary interview scores showed a strong association (P < .005), suggesting that the summary interviewer, who had access to the full applicant file, and the CBBI interviewer, who did not, assessed similar strengths despite the 2 different approaches, or that the strengths assessed tracked in the same direction. Students whose 2 interview scores were not aligned were less likely to be accepted to the school.
    Next steps: The review raised awareness about the cultural aspects of interpreting the competencies and the need to expand our cultural framework throughout interviewer training. Findings indicate that CBBIs have the potential to reduce bias related to over-reliance on standardized metrics; however, additional innovation and research are needed.
    Language English
    Publishing date 2024-03-25
    Publishing country United States
    Document type Journal Article
    ZDB-ID 96192-9
    ISSN 1938-808X ; 1040-2446
    ISSN (online) 1938-808X
    ISSN 1040-2446
    DOI 10.1097/ACM.0000000000005708
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sézary Syndrome.

    Zic, John A

    Dermatologic clinics

    2015  Volume 33, Issue 4, Page(s) 765–776

    Abstract: Extracorporeal photopheresis (ECP) is an immunomodulating procedure that leads to an expansion of peripheral blood dendritic cell populations and an enhanced TH1 immune response in cutaneous T-cell lymphoma (CTCL). Because of its excellent side effect ... ...

    Abstract Extracorporeal photopheresis (ECP) is an immunomodulating procedure that leads to an expansion of peripheral blood dendritic cell populations and an enhanced TH1 immune response in cutaneous T-cell lymphoma (CTCL). Because of its excellent side effect profile and moderate efficacy, ECP is considered first-line therapy for erythrodermic mycosis fungoides (MF) and Sézary syndrome. Patients with a measurable but low blood tumor burden are most likely to respond to ECP, and the addition of adjunctive immunostimulatory agents may also increase response rates. There may be a role for ECP in the treatment of refractory early stage MF, but data are limited.
    MeSH term(s) Antineoplastic Agents/therapeutic use ; Chemotherapy, Adjuvant/methods ; Humans ; Immunomodulation ; Methoxsalen/pharmacokinetics ; Methoxsalen/therapeutic use ; Mycosis Fungoides/drug therapy ; Mycosis Fungoides/mortality ; Photopheresis/adverse effects ; Photopheresis/methods ; Photosensitizing Agents/pharmacokinetics ; Photosensitizing Agents/therapeutic use ; Sezary Syndrome/drug therapy ; Sezary Syndrome/mortality ; Skin Neoplasms/drug therapy ; Skin Neoplasms/mortality ; Treatment Outcome
    Chemical Substances Antineoplastic Agents ; Photosensitizing Agents ; Methoxsalen (U4VJ29L7BQ)
    Language English
    Publishing date 2015-10
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 82798-8
    ISSN 1558-0520 ; 0733-8635
    ISSN (online) 1558-0520
    ISSN 0733-8635
    DOI 10.1016/j.det.2015.05.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Photopheresis in the treatment of cutaneous T-cell lymphoma: current status.

    Zic, John A

    Current opinion in oncology

    2012  Volume 24 Suppl 1, Page(s) S1–10

    Abstract: Cutaneous T-cell lymphoma is the overall name for a group of malignancies in which malignant T-lymphocytes localize at the skin. Of the current 20 recognized subtypes of the disease, the most common are mycosis fungoides and Sézary syndrome. ... ...

    Abstract Cutaneous T-cell lymphoma is the overall name for a group of malignancies in which malignant T-lymphocytes localize at the skin. Of the current 20 recognized subtypes of the disease, the most common are mycosis fungoides and Sézary syndrome. Extracorporeal photopheresis (ECP), an immunomodulating procedure that treats pheresed blood with a photoactive agent, received US Food and Drug Administration approval in 1988 as a medical device for the treatment of CTCL patients, one of many treatment options for such patients. This was followed in 2003 by guidelines in the United Kingdom that recommended ECP for patients with advanced CTCL, particularly after skin-directed treatment options have failed. ECP is now under investigation for use in patients with earlier stages of CTCL. This article reviews the evolution of the ECP technique--for example, the most recent generation of the device requires a lower extracorporeal volume of blood than the previous version did, thus making it possible for more patients to be candidates for the procedure. In addition, there has been progress in understanding how ECP works at the cellular level.
    MeSH term(s) Humans ; Lymphoma, T-Cell, Cutaneous/drug therapy ; Photopheresis/methods ; Photopheresis/trends ; Skin Neoplasms/drug therapy
    Language English
    Publishing date 2012-01
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1049384-0
    ISSN 1531-703X ; 1040-8746
    ISSN (online) 1531-703X
    ISSN 1040-8746
    DOI 10.1097/01.cco.0000410158.56500.c4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Controversies in the management of the cutaneous T cell lymphomas.

    Zic, John A

    Dermatologic therapy

    2009  Volume 22, Issue 5, Page(s) 407–417

    Abstract: The primary cutaneous T cell lymphomas (CTCL) encompass all malignancies of the T cell where the skin is the primary organ of involvement. The diagnosis of a CTCL variant can be detoured by a number of obstacles including the slow evolution of the ... ...

    Abstract The primary cutaneous T cell lymphomas (CTCL) encompass all malignancies of the T cell where the skin is the primary organ of involvement. The diagnosis of a CTCL variant can be detoured by a number of obstacles including the slow evolution of the disease into a classic clinical and pathologic pattern. A realistic goal of early stage treatment is to reduce the likelihood of progression to a more advanced stage, not to achieve a cure. No studies have adequately compared the different systemic agents in patients with advanced CTCL so the clinician is left to act in the best interest of the patient with what evidence is available. When using the systemic agents, a "start low and go slow" strategy may offer patients several advantages. Dermatologists are uniquely trained to diagnose and to manage all but the most advanced stage patients with CTCL.
    MeSH term(s) Dermatology/organization & administration ; Disease Progression ; Humans ; Lymphoma, T-Cell, Cutaneous/diagnosis ; Lymphoma, T-Cell, Cutaneous/pathology ; Lymphoma, T-Cell, Cutaneous/therapy ; Mycosis Fungoides/diagnosis ; Mycosis Fungoides/therapy ; Neoplasm Staging ; Referral and Consultation ; Skin Neoplasms/diagnosis ; Skin Neoplasms/pathology ; Skin Neoplasms/therapy
    Language English
    Publishing date 2009-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1354801-3
    ISSN 1529-8019 ; 1396-0296
    ISSN (online) 1529-8019
    ISSN 1396-0296
    DOI 10.1111/j.1529-8019.2009.01257.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Clinical Best Practices for Radiation Safety During Lutetium-177 Therapy.

    Cappon, Derek John / Fang, Susanna / Berry, Kendall / Capone, Gina / Carlton, Gina L / Chrétien, Mario / Gough, John / Kamen, Jacob / Khoorshed, Anne / Miller, Andy / Nelli, Stephen / Petric, M Peter / Tourneur, Frank / Zic, Josip J

    Health physics

    2022  Volume 124, Issue 2, Page(s) 139–146

    Abstract: Importance: 177 Lu therapy as part of theranostic treatment for cancer is expanding but it can be a challenge for sites with limited radiation protection staff to implement the radiation safety program required for therapeutic nuclear medicine.: ... ...

    Abstract Importance: 177 Lu therapy as part of theranostic treatment for cancer is expanding but it can be a challenge for sites with limited radiation protection staff to implement the radiation safety program required for therapeutic nuclear medicine.
    Objective: To increase the adoption of 177 Lu therapy, especially in smaller centers and clinics, by providing a collection of radiation safety best practices and operational experience. To provide a resource for radiation safety officers supporting the implementation of a 177 Lu therapy program.
    Methods: A panel of 11 radiation safety professionals representing sites across Canada and the United States with experience delivering 177 Lu therapy was assembled and discussed their responses to a list of questions focused on the following radiation safety topics: facility layout and design; radiation safety program; and drug management and patient care.
    Results: A comprehensive set of best practice guidelines for clinical radiation safety during 177 Lu therapy has been developed based on the collective operational experience of a group of radiation safety professionals. Significant findings included that 177 Lu therapy is often safely administered in unshielded rooms, that staff radiation exposure associated with 177 Lu therapy is minimal relative to other nuclear medicine programs, and that some relatively simple preparation in advance including papering of common surfaces and planning for incontinence can effectively control contamination during therapy.
    Conclusion: The guidance contained in this paper will assist radiation safety professionals in the implementation of safe, effective 177 Lu therapy programs, even at smaller sites with limited to no experience in therapeutic nuclear medicine.
    MeSH term(s) Humans ; Radioisotopes/adverse effects ; Radiation Protection ; Lutetium/therapeutic use ; Nuclear Medicine
    Chemical Substances Lutetium-177 (BRH40Y9V1Q) ; Radioisotopes ; Lutetium (5H0DOZ21UJ)
    Language English
    Publishing date 2022-12-10
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2406-5
    ISSN 1538-5159 ; 0017-9078
    ISSN (online) 1538-5159
    ISSN 0017-9078
    DOI 10.1097/HP.0000000000001644
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Intraocular involvement of mycosis fungoides associated with immunophenotypic switch from CD4

    Braue, Jonathan A / Daniels, Anthony B / Zwerner, Jeffrey P / Kim, Stephen J / Zic, John A

    Blood

    2018  Volume 131, Issue 8, Page(s) 932–935

    MeSH term(s) Aged ; CD4 Antigens/immunology ; CD4 Antigens/metabolism ; CD8 Antigens/immunology ; CD8 Antigens/metabolism ; Eye Diseases/complications ; Eye Diseases/immunology ; Eye Diseases/metabolism ; Eye Diseases/pathology ; Female ; Humans ; Immunophenotyping ; Middle Aged ; Mycosis Fungoides/complications ; Mycosis Fungoides/immunology ; Mycosis Fungoides/metabolism ; Mycosis Fungoides/pathology ; Prognosis ; Skin Neoplasms/complications ; Skin Neoplasms/immunology ; Skin Neoplasms/metabolism ; Skin Neoplasms/pathology
    Chemical Substances CD4 Antigens ; CD8 Antigens
    Language English
    Publishing date 2018-01-03
    Publishing country United States
    Document type Case Reports ; Letter ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood-2017-11-814194
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Prospective observational trial of low-dose skin electron beam therapy in mycosis fungoides using a rotational technique.

    Newman, Neil B / Patel, Chirayu G / Ding, George X / Zic, John A / Zwerner, Jeffrey / Osmundson, Evan C / Kirschner, Austin N

    Journal of the American Academy of Dermatology

    2020  Volume 85, Issue 1, Page(s) 121–127

    Abstract: Introduction: Low-dose total skin electron beam therapy provides a durable treatment response for skin lesions caused by cutaneous T-cell lymphoma. We prospectively assessed the durability of response and quality of life for patients receiving low-dose ... ...

    Abstract Introduction: Low-dose total skin electron beam therapy provides a durable treatment response for skin lesions caused by cutaneous T-cell lymphoma. We prospectively assessed the durability of response and quality of life for patients receiving low-dose total skin electron beam therapy using a novel rotational technique and dosing regimen.
    Methods: Patients completed baseline Skindex-29 quality-of-life surveys and had baseline Modified Severity-Weighted Assessment Tool score recorded. Patients received 12 Gy in 12 fractions with a dual-field rotational technique. The primary outcome was overall response rate, with the secondary outcomes being time to treatment response, duration of clinical benefit, and quality-of-life change.
    Results: We enrolled 20 patients and recorded an overall response rate of 90%. The median time to treatment response was 6.5 weeks. The baseline Modified Severity-Weighted Assessment Tool score was 55.6 and it declined to a median of 2.2 at last follow-up (P < .001). The median duration of clinical benefit was 21 months. There was a decline in the Skindex-29 total score and every subdomain when each follow-up visit was compared (P = .004).
    Conclusions: This prospective study demonstrated a very high overall response rate and improvement in skin-related quality of life. Low-dose rotational total skin electron beam therapy can be implemented routinely in clinical practice.
    MeSH term(s) Aged ; Female ; Humans ; Male ; Middle Aged ; Mycosis Fungoides/radiotherapy ; Prospective Studies ; Quality of Life ; Radiotherapy/methods ; Radiotherapy Dosage ; Severity of Illness Index ; Skin Neoplasms/radiotherapy ; Surveys and Questionnaires ; Time-to-Treatment ; Treatment Outcome
    Language English
    Publishing date 2020-12-14
    Publishing country United States
    Document type Journal Article ; Observational Study
    ZDB-ID 603641-7
    ISSN 1097-6787 ; 0190-9622
    ISSN (online) 1097-6787
    ISSN 0190-9622
    DOI 10.1016/j.jaad.2020.12.023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Single-cell immunopathology of systemic contact allergy associated with corticosteroids.

    Hertzman, Rebecca J / Deshpande, Pooja / White, Katie D / Gangula, Rama / Chopra, Abha / Ram, Ramesh / Zic, John A / Zwerner, Jeffrey P / Gibson, Andrew / Phillips, Elizabeth J

    Journal of dermatological science

    2021  Volume 105, Issue 2, Page(s) 137–140

    MeSH term(s) Adrenal Cortex Hormones/adverse effects ; Dermatitis, Allergic Contact ; Humans ; Patch Tests
    Chemical Substances Adrenal Cortex Hormones
    Language English
    Publishing date 2021-12-17
    Publishing country Netherlands
    Document type Letter
    ZDB-ID 1024446-3
    ISSN 1873-569X ; 0923-1811
    ISSN (online) 1873-569X
    ISSN 0923-1811
    DOI 10.1016/j.jdermsci.2021.12.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top